Over 100 global leaders appeal to declare covid-19 vaccines a common good

Over 100 global leaders, thinkers and industrialists including Ratan Tata, NR Narayana Murthy, Kailash Satyarthi and Shabana Azmi have joined Nobel peace prize winner Muhammad Yunus in an appeal to declare Covid-19 vaccines a global common good so that the vaccines can be produced and distributed for free.
Source: The Economic Times - Category: Consumer Health News Source Type: news

Related Links:

Falling immunization rates could jeopardize the future of COVID-19 vaccination programs.Medscape Internal Medicine
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Internal Medicine Commentary Source Type: news
The contract represents a major bet on the Gaithersburg biotech ’s coronavirus work as the country hustles to find a viable vaccine to help end the pandemic.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
CONCLUSION: We hope that this study could provide information on high risk groups for preemptive interventions. In the future, if a vaccine for COVID-19 is developed, it is expected that this study will be the basic data for recommending immunization by selecting those with chronic disease that had high risk of death, as recommended target diseases for vaccination. PMID: 32627443 [PubMed - in process]
Source: Journal of Korean Medical Science - Category: Biomedical Science Tags: J Korean Med Sci Source Type: research
Authors: Im JH, Nahm CH, Baek JH, Kwon HY, Lee JS Abstract Coronavirus disease 2019 (COVID-19) is rapidly spreading around the world, causing much morbidity and mortality everywhere. However, effective treatments or vaccines are still not available. Although convalescent plasma (CP) therapy can be useful in the treatment of COVID-19, it has not been widely used in Korea because of the concerns about adverse effects and the difficulty in matching patients to donors. The use of ABO-incompatible plasma is not contraindicated in treatment, but can be hesitated due to the lack of experience of physicians. Here, we descr...
Source: Journal of Korean Medical Science - Category: Biomedical Science Tags: J Korean Med Sci Source Type: research
Three pending Bay Area biotech IPOs and follow-on offerings from four other drug makers could collectively raise more than $1.1 billion, highlighting biotech's latest Wall Street resurgence amid hope for new cancer treatments and drugs and vaccines targeting Covid-19. Annexon Inc., which said last week that it raised $100 million, marked its place for an initial public offering of $100 million filing as Nurix Therapeutics Inc. declared its intentions for a $100 million IPO and Nkarta Inc. detailed…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
The idea involves a controversial type of medical study known as a human challenge trial.
Source: L.A. Times - Health - Category: Consumer Health News Authors: Source Type: news
(Natural News) Clamped down by communist control, the Chinese people are being marched toward permanent bodily requirements — their DNA surrendered over to the state and their immune systems sacrificed to and engineered by pharmaceutical companies. In China, there are four major drug manufacturers working on a seasonal covid-19 inoculation — CanSino Biologics, the Wuhan...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
(Natural News) During a recent interview with TIME, Melinda Gates, co-chair of the infamous Bill &Melinda Gates Foundation, spelled out the order in which she believes people need to be vaccinated for the Wuhan coronavirus (COVID-19). First in line after health care workers, she divulged, will be black people, which are supposedly more at...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
(Natural News) Africans are finally waking up to the deception of the experimental vaccination campaigns that continue to be thrust upon them in the name of advancing “public health,” and the globalist overlords behind it all are beginning to quake in their boots. A recent protest in South Africa saw dozens of concerned Africans publicly...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
Emergent BioSolutions Inc. said Monday it has signed a five-year agreement with Johnson&Johnson to manufacture its Covid-19 vaccine candidate, just a couple of months after striking a $135 million deal for the first step of their collaboration. For the first two years of the deal, valued at $480 million, the Gaithersburg biotech will serve as a contract development and manufacturing organization (CDMO) to Janssen Pharmaceuticals, Inc., part of New Brunswick, New Jersey-based Johnson&Johnson …
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
More News: COVID-19 | Health | Vaccines